<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02593669</url>
  </required_header>
  <id_info>
    <org_study_id>CCPMOH2010-China8</org_study_id>
    <nct_id>NCT02593669</nct_id>
  </id_info>
  <brief_title>The Effect of Cataract Surgery on Sleep Quality</brief_title>
  <official_title>The Effect of Cataract Surgery for Age-related Cataract Patients on Circadian Rhythm and Sleep Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cataract is a clouding of the crystalline lens inside the eye, which leads to a decrease in
      vision. It is the most prevalent, treatable cause of visual impairment and blindness in the
      world. Cataract surgery with an intraocular lens (IOL) implant is one of the most common and
      thought to be the most effective surgical procedure in any field of medicine. In this trial,
      the investigators aimed to evaluate the effect of cataract surgery on circadian rhythm and
      sleep as well as the effect of the blue light transmission characteristics of the implanted
      IOL on sleep.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Prospective, randomized controlled study of 10000 participants(20000 eyes) with dense
      nucleus were enrolled. Patients were assigned to two groups: Group I: neutral IOL implanted
      in eye while in Group II, blue-blocking IOL was innovatively implanted in the eye.

      A cataract is a clouding of the crystalline lens inside the eye, which leads to a decrease in
      vision. It is the most prevalent, treatable cause of visual impairment and blindness in the
      world. Cataract surgery with an intraocular lens (IOL) implant is one of the most common and
      thought to be the most effective surgical procedure in any field of medicine.

      In this trial, the investigators aimed to evaluate the effect of cataract surgery on
      circadian rhythm and sleep as well as the effect of the blue light transmission
      characteristics of the implanted IOL on sleep. Patients enrolled into the study will be
      assessed in 3 months before the surgery and 3 months after the surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Post-illumination pupil response (PIPR)</measure>
    <time_frame>3 months before the surgery and 3 months after the surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Objective sleep quality:actigraphy</measure>
    <time_frame>3 months before the surgery and 3 months after the surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Subjective sleep quality: PSQI</measure>
    <time_frame>3 months before the surgery and 3 months after the surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Cataract</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Neutral IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phacoemulsification cataract surgery is performed with neutral IOL implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blue-blocking IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phacoemulsification cataract surgery is performed with blue-blocking IOL implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacomulsification lens removal cataract surgery with neutral Intraocular lens(IOL) implantation</intervention_name>
    <description>The phacoemulsification lens removal cataract surgery is performed with neutral IOL.implantation</description>
    <arm_group_label>Neutral IOL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacomulsification lens removal cataract surgery with blue-blocking Intraocular lens(IOL) implantation</intervention_name>
    <description>The phacoemulsification lens removal cataract surgery is performed with blue-blocking IOL.implantation.</description>
    <arm_group_label>Blue-blocking IOL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Subconjunctival dexamethasone and general anesthesia</intervention_name>
    <description>All patients received subconjunctival dexamethasone (2 mg) during surgery, and all surgeries were performed under general anesthesia.</description>
    <arm_group_label>Neutral IOL</arm_group_label>
    <arm_group_label>Blue-blocking IOL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Viscoelastic materials</intervention_name>
    <description>viscoelastic materials are used to protect corneal endothelial cells.</description>
    <arm_group_label>Neutral IOL</arm_group_label>
    <arm_group_label>Blue-blocking IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral age-related cataract scheduled for cataract surgery

        Exclusion Criteria:

          -  Vision-impairing ophthalmic disease: Glaucoma, AMD, DR.et.al

          -  Severe systemic disease: Diabetes, Sleep disorder.et.al

          -  Vision-impairing complications: Ruptured posterior capsule, Persistent cornea
             edema.et.al
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haotian Lin, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yizhi Liu, M.D., Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Weirong Chen, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haotian Lin, M.D., Ph.D.</last_name>
      <phone>8613802793086</phone>
      <email>haot.lin@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jing Li, M.D.</last_name>
      <phone>+86-20-87330341</phone>
      <email>Reviewborad_SYsU@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.gzzoc.com/</url>
    <description>Description Home page of Zhongshan Ophthalmic Center</description>
  </link>
  <reference>
    <citation>Br√∏ndsted AE, Sander B, Haargaard B, Lund-Andersen H, Jennum P, Gammeltoft S, Kessel L. The Effect of Cataract Surgery on Circadian Photoentrainment: A Randomized Trial of Blue-Blocking versus Neutral Intraocular Lenses. Ophthalmology. 2015 Oct;122(10):2115-24. doi: 10.1016/j.ophtha.2015.06.033. Epub 2015 Jul 30.</citation>
    <PMID>26233628</PMID>
  </reference>
  <reference>
    <citation>Ayaki M, Negishi K, Tsubota K. Rejuvenation effects of cataract surgery with ultraviolet blocking intra-ocular lens on circadian rhythm and gait speed. Rejuvenation Res. 2014 Aug;17(4):359-65. doi: 10.1089/rej.2014.1550.</citation>
    <PMID>24701992</PMID>
  </reference>
  <reference>
    <citation>Ayaki M, Muramatsu M, Negishi K, Tsubota K. Improvements in sleep quality and gait speed after cataract surgery. Rejuvenation Res. 2013 Feb;16(1):35-42. doi: 10.1089/rej.2012.1369.</citation>
    <PMID>23145881</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2015</study_first_submitted>
  <study_first_submitted_qc>October 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2015</study_first_posted>
  <last_update_submitted>October 30, 2015</last_update_submitted>
  <last_update_submitted_qc>October 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Haotian Lin</investigator_full_name>
    <investigator_title>Principal Investigator, Home for Cataract Children, Zhongshan Ophthalmic Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

